Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Top Cited Papers
Open Access
- 20 June 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 17 (8), 1047-1060
- https://doi.org/10.1016/s1470-2045(16)30102-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patientsRadiation Oncology, 2013
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?International Journal of Radiation Oncology*Biology*Physics, 2013
- Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patientsActa Oncologica, 2012
- Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) GyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Acute and Late Toxicity in a Randomized Trial of Conventional Versus Hypofractionated Three-Dimensional Conformal Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)International Journal of Radiation Oncology*Biology*Physics, 2010
- Question of Dose, Fractionation and Technique: Ingredients for Testing Hypofractionation in Prostate Cancer – the CHHiP TrialClinical Oncology, 2008
- A Comparison of Treatment Planning Techniques Used in Two Randomised UK External Beam Radiotherapy Trials for Localised Prostate CancerClinical Oncology, 2008
- LENT SOMA tables table of contentsRadiotherapy and Oncology, 1995
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995